Uitgebreid zoeken

Dr. Camille L. Bedrosian, MD, is onafhankelijk bestuurder bij Rhythm Pharmaceuticals, Inc., onafhankelijk bestuurder bij Crinetics Pharmaceuticals, Inc., Chief Medical Officer & Executive Vice President bij Ultragenyx Pharmaceutical, Inc., lid van de American Society of Clinical Oncology, lid van de American Society of Hematology en lid van de American Society of Nephrology. Zij zetelt in de Raad van Bestuur van Rhythm Pharmaceuticals, Inc. en Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was voorheen werkzaam als Chief Medical Officer & Senior Vice President bij Alexion Pharmaceuticals, Inc., als Chief Medical Officer & Vice President bij ARIAD Pharmaceuticals, Inc., als Senior Director-Oncology & Hematology bij Genetics Institute, Inc., als lid bij de American Association for Cancer Research, als lid bij de American Association for the Advancement of Science, als lid bij Duke Comprehensive Cancer Center, en als assistent-professor bij Duke University Medical Center. Zij behaalde haar doctoraal aan de Harvard University, haar doctoraal aan het Massachusetts Institute of Technology en haar doctoraal aan de Harvard Medical School.

Momenteel is Camille Bonnel Head-Research bij Tritax Big Box REIT Plc. In het verleden was mevrouw Bonnel Research Analyst bij Merrill Lynch International en Analyst bij RBC Europe Ltd. (Broker). (Makelaar).

Camille Jojo is currently working as the Executive Director & Head-Legal & Compliance at Techtronic Industries Co., Ltd.
Prior to this, Mr. Jojo worked as a Member at the Chartered Institute of Arbitrators (East Asia Branch) and as a Partner at Norton Rose Fulbright (Services) Ltd.
Mr. Jojo graduated from the University of Cardiff in 1977.

Mevrouw Camille Burckhart is Chief Information & Digital Officer, Executive VP bij Popular, Inc. Zij zit in de Raad van Bestuur van Fundacin Banco Popular, Inc. en Nuestra Escuela, Inc.

Romain Camille Zaleski is currently the Chief Executive Officer & Director at Carlo Tassara SpA since 2021.
He is also the Chairman & President at Carlo Tassara France SAS since 2019.
Previously, he held positions as Vice Chairman at Mittel SpA, Director at ArcelorMittal SA, Director at Metalcam SpA, and Director at ArcelorMittal NV.
Mr. Zaleski completed his undergraduate degree at Ecole Polytechnique in 1958.

Momenteel bekleedt Grard Rene Camille Deman de functie van Voorzitter & Chief Executive Officer voor Drakkar Holdings SA en Voorzitter voor Adisseo France SAS. Hij zit ook in de raad van bestuur van China National BlueStar (Group) Co, Ltd., Bluestar Adisseo Co. (voormalig Voorzitter) en Bluestar Adisseo Nutrition Group Ltd. De heer Deman was voorheen Director-Manufacturing, Purchasing & Supply Chain bij Aventis Animal Nutrition, Inc. en Vice President-Corporate Manufacturing bij Solvay France SA.

Richard Bedrosian has worked as a Managing Partner at Moderne Communications, Inc. in New York.

John C.
Bedrosian is currently a Director at The International Dairy Foods Association, All Star Dairy Foods, Inc., and Dairy Institute of California.
He was formerly a Director at The American Institute of Baking and Vice President-Manufacturing at UNFI Grocers Distribution, Inc. Bedrosian obtained an undergraduate degree from The California State University.

Mr. Bedrosian serves as the Chief Financial Office of Marcus & Millichap Company and is responsible for overseeing the entire finance function, including, capital markets, taxation, and treasury.
He also serves as a member of the Company's Investment Committee.
Mr. Bedrosian has significant experience within the real estate investment banking community and has acted as a strategic advisor to many private and public companies within the sector.
Prior to joining Marcus & Millichap Company, he was the Chief Financial Officer at Ramco-Gershenson Properties Trust, a publically-traded REIT, and served as the Managing Director in the Global Real Estate Investment Banking Group at Deutsche Bank Securities, Inc. Mr. Bedrosian earned a B.S.
in Finance and Administration from Mercy College and an M.S.
in Real Estate and Finance from New York University.

Gregory R.
Bedrosian is the founder of The Sputnik Group (1995) and Renaissance Capital KK (1995), where he held the title of Co-Partner.
He is also the founder of Redwood Capital Group LLC.
Currently, he holds the position of Chief Executive Officer & Director at Drake Star Partners Ltd., President, Co-Chief Executive Officer & Director at Drake Star Partners, Inc., Non-Executive Chairman of the Investment Committee at Da Vinci Capital Llc (since 2020), and Director at Redwood Capital (Europe) Ltd.
(since 1999).
In the past, he worked as a Principal at CSFB Private Equity Partners LLC (1992-1995) and at Inventures Ltd.

Arthur P.
Bedrosian served as the Chief Executive Officer & Director of Lannett Co., Inc. from 2014 to 2018.
Prior to that, he was the President & Chief Executive Officer of Trinity Laboratories, Inc. from 1999 to 2001.
He also served as the President & Chief Executive Officer of Kremers Urban Pharmaceuticals, Inc. Bedrosian received his undergraduate degree from Queens College and his graduate degree from Newport University.

Camille F.
Sarrouf is currently the Director at St. Jude Children's Research Hospital, Inc. He previously served as the Chairman at American Lebanese Syrian Associated Charities, Inc.

Camille I.
Farhat currently works at Safeguard Medical LLC, as Executive Chairman from 2022, Advanced Medical Technology Association, as Director, Northwestern Memorial Hospital, as Advisory Council Member, and Water Street Healthcare Partners LLC, as Executive Advisor from 2021.
Mr. Farhat also formerly worked at Surgalign Spine Technologies, Inc., as President, Chief Executive Officer & Director, American Medical Systems, Inc., as President & CEO from 2012 to 2015, Surgalign Holdings, Inc., as President, Chief Executive Officer & Director from 2017 to 2020, RTI Surgical, Inc. (Florida), as President & Chief Executive Officer from 2017 to 2020, Cardiac Science Corp., as Director from 2016 to 2019, CMR Surgical Ltd., as Director from 2018 to 2021, Lau Health Foundation, Inc., as Director from 2011 to 2016, Baxter International, Inc., as Global GM-Baxter Pharmaceuticals & Technologies from 2008 to 2011, General Electric Financial Services, Inc., as Principal from 1993 to 2001, Medtronic, Inc., as Vice President-Business Development from 2003 to 2006, Astora Women's Health, Inc., as President, NXThera, Inc., as Board Member from 2012 to 2015, GE Healthcare (Ventures), as Principal from 2001 to 2003, and Global Infusion Systems, as Principal.
Mr. Farhat received his Masters Business Admin degree in 1998 from Harvard University, undergraduate degree in 1991 from Northeastern University, and undergraduate degree from Sciences Po.

Camille R.
Bash is currently the Chief Financial Officer & Treasurer at Doctors Hospital, Inc. and a Fellow at Healthcare Financial Management Association.
Previously, she worked as the Chief Financial Officer at Washington Homes, Inc., Vice President-Business Operations at Children's National Hospital (District of Columbia), Administrator at Medlink Hospital & Nursing Center, and Chief Financial Officer at Catholic Charities.
Dr. Bash holds an MBA from the University of Missouri, an undergraduate degree from The University of Texas at Austin, and a graduate degree from Webster University.

Camille Verchery is the CEO of VVR International SARL since 2012.
He obtained an undergraduate degree from École Supérieure de Commerce et de Management.

Camille Alexander is currently a Director at Schurz Communications, Inc. Previously, she worked as an Operations Manager at Meetup, Inc.

Camille M.
Romano is currently the Chief Financial Officer at Woodwell Climate Research Center, Inc. She started this position in 2019 and is still currently employed there.
In terms of education, Ms. Romano has a graduate degree from Northeastern University and an undergraduate degree from the University of Massachusetts.

Camille H.
Gamble worked as a Marketing Director at Rapsheets.com, a Principal at Lexisnexis Risk Assets, Inc., and a Vice President-Marketing & Support at Verified Person, Inc. She obtained an undergraduate degree from Auburn University.

Camille Lee worked as Senior Vice President-Alzheimer Therapeutic Area at Biogen, Inc. from 2017 to 2018.
Prior to that, she was Vice President-Diabetes Marketing at Novo Nordisk, Inc. in 2013.
She also held the position of Vice President-International Marketing at Zürichsee Druckereien AG.
Ms. Lee earned an undergraduate degree from The California State University and an MBA from Scandinavian International Management Institute.

Camille V.
Otero is currently the Director-Real Property & Environmental at Gibbons PC, and a Member of both the New York State Bar Association and the New Jersey State Bar Association.
She received her undergraduate degree from Bloomfield College in 1995 and her graduate degree from Rutgers State University of New Jersey in 1998.

Ms. Camille S.
Andrews is Of Counsel at Context Capital Partners.
She brings more than 20 years of experience as a successful commercial litigator, law professor, and law school dean to her role with Context Capital Partners.
Additionally, Ms. Andrews has vast experience in complex commercial litigation, including antitrust, securities, corporate counseling, derivative shareholder litigation, and trademark and trade secret law.
Ms. Andrews was most recently both a litigation partner with the Philadelphia based firm of Dilworth Paxson, LLP, and an Associate Dean and Faculty member at Rutgers Law School.
At Rutgers, she taught Professional Responsibility (Ethics), Complex Litigation, Antitrust, Evidence,and Federal Practice.
In addition to her teaching duties, she also oversaw Enrollment and ICLE outreach courses to the bar.
In her capacity as Dean, she served as a member of the Judicial Clerkship Committee, Academic Petitions Committee, and faculty advisor to the Law Journal.
Ms. Andrews is admitted to practice before the U.S.
Supreme Court, New Jersey and Pennsylvania Supreme Courts, U.S.
District Courts for the Eastern District of Pennsylvania, Middle District of Pennsylvania & District of New Jersey, and the U.S.
Courts of Appeal for the Third & Second Circuits.
She is a member of several charitable boards, including Walnut Street Theatre, ACYO Foundation and New Jersey Child Cares.
She is married to Congressman Rob Andrews, and they have two daughters, Jackie and Josie.
The Andrews family lives in Haddon Heights, NJ.
Ms. Andrews received her undergraduate degree from the University of Pittsburgh and a graduate degree from Rutgers University.

Camille Simeon formerly worked at abrdn Australia Ltd., as Investment Director from 2020 to 2023.

Camille DeLuca-Flaherty worked as a Director of Development Project Management at Exelixis, Inc. from 1998 to 2012.
She also worked as a Vice President of Project Management at Catalyst Bioscience, Inc. and as a Principal at Affymax, Inc. and Sandoz Agro, Inc. Dr. DeLuca-Flaherty holds a doctorate degree from The University of Colorado.

Camille A.
Gerard is the founder of Risk Management Consulting LLC, which was founded in 2005.
Ms. Gerard's current job is as a Controller at Badlands Energy, Inc., starting in 2008.
Ms. Gerard has an MBA from Louisiana State University and an undergraduate degree from the University of Louisiana at Lafayette.

Camille Delibes has a current job as a Partner at Omnes Capital SAS.

Camille Thommes worked as the Director General for the Association of the Luxembourg Fund Industry from 2007 to 2024.

Camille Cleveland is the General Counsel at Blue Nile, Inc. She previously worked as the Senior Vice President & General Counsel at A Place for Mom, Inc., the Executive Vice President & General Counsel at Big Boy Restaurant Group LLC, the Vice President & General Counsel at Entertainment Publications LLC, the Senior Legal Counsel at Ticketmaster Australasia Pty Ltd., and the Vice President & General Counsel at Papyrus-Recycled Greetings, Inc. Cleveland received her undergraduate degree from Albion College and her graduate degree from Wayne State University Law School.

Camille Landis worked as the Vice President of Business Development at Relypsa, Inc. from 2015 to 2017.
Prior to that, she was the Senior Vice President of Corporate Development at Unity Biotechnology, Inc. and the Chief Business Officer at Eidos Therapeutics, Inc. Ms. Landis received an undergraduate degree from the University of St. Thomas and an MBA from the Haas School of Business.

Camille Tan worked as a Sales & Trading Analyst at Deutsche Bank Securities, Inc. in 2014.
She also worked as an Analyst at Scotia Capital, Inc. (Broker).
From 2015 to 2018, she worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Ms. Tan received her undergraduate degree from The University of Waterloo in 2014.

Camille Waxer has held director positions in three different companies, including Canary Wharf Group Plc, Canary Wharf Management Ltd., and Canada Square (Pavilion) Ltd.
He currently holds director positions in all three companies.

Camille E.
Slone is currently the Treasurer & Director at Slone Lumber Co., Inc.

Camille Claverie is a Non-Executive Director at ME Group International Plc since 2021.
Prior to this, Camille was a Partner at Montefiore Investment SAS starting in 2019.
Camille's former position was as a Director at Sagard SAS from 2015 to 2019.
Camille completed their graduate degree at École des Hautes Études Commerciales de Paris in 2007.

Camille P.
Wicher is currently the Vice President-Clinical Operations at Roswell Park Comprehensive Cancer Center since 1997.
She received a graduate degree from the State University of New York at Buffalo in 1987 and a doctorate degree from the same institution in 2013.

Camille R.
Robinson-Regis is currently a Member-Governors Board at the Inter-American Development Bank, Minister of Housing & Urban Development in the Government of Trinidad & Tobago, and a Member-Governors Board at the Inter-American Investment Corp.

Camille Fronville is currently working as an Investment Officer at BIO NV.

Camille Pinette is currently an Independent Director at Namex Ventures, Inc. and the Chief Financial Officer & Non-Independent Director at Preferred Dental Technologies, Inc. He was previously the Controller at Preferred Dental Implant Corp.
Mr. Pinette has also worked as a Director at IGC Resources, Inc. and as the CFO, Secretary, Director & Controller at Whitewater Capital Corp.

Camille Bonenfant currently works at ENGIE CC SCRL, as Director, Conces Franc Const Expl Tunnel Mont Blanc SA, as Director from 2019, and Storengy France SA, as Director.
Ms. Bonenfant also formerly worked at Compagnie Parisienne de Chauffage Urbain SA, as Deputy Chief Executive Officer in 2018, SFIG, as Chairman, ENGIE Énergie Services SA, as Director, and ENGIE SA, as Secretary.
Ms. Bonenfant received her graduate degree from Sciences Po.

Camille (Cami) focuses on healthcare with an emphasis on biotech, medical devices, and consumer health.
Temperamentally an early-stage investor and company helper, Cami currently serves on the board of Cavalry, Iris, Mahzi, Ocelot, Unity (UBX), and is a board observer at Interdict.
She previously served on the board of several exited Venrock portfolio companies, including Corvidia (sold to Novo), RegenXBio (RGNX), and Spirox (owned by Stryker).
Prior to Venrock, Cami was a Managing Director at Versant Ventures where she served on the board (or as a board observer) at many companies including Genomic Health (GHDX/sold to Exact), Jazz (JAZZ), Kythera (KYTH/sold to Allergan), and Novacardia (sold to Merck).
During her early career, Cami worked in corporate development at Genzyme, Millennium Predictive Medicine, and Tularik, and she was a management consultant at LEK.
Cami earned her Bachelor’s degree in Biology from Duke University and an MBA from Harvard Business School (HBS), where she graduated as a Baker Scholar.
She is a Henry Crown Fellow, serves on the Investment Advisory Committee of Mission BioCapital (MBC), and serves on the HBS Global Advisory Board.